Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
156 studies found for:    "neurofibromatosis type 2" OR "neurofibromatosis"
Show Display Options
Rank Status Study
21 Recruiting Neurofibromatosis Type 1 Patient Registry
Condition: Neurofibromatosis Type 1
Intervention:
22 Unknown  Modifying Genes in Neurofibromatosis 1
Condition: Neurofibromatosis 1
Intervention: Other: No intervention
23 Active, not recruiting A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1
Interventions: Drug: Lovastatin ™;   Device: placebo
24 Recruiting Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
Condition: Neurofibromatoses
Interventions: Behavioral: Stress Management Group 1;   Behavioral: Stress Management Group 2
25 Completed Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
Condition: Neurofibromatosis 1
Interventions: Drug: Lovastatin;   Drug: placebo pill
26 Completed Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1
Intervention: Other: Neuropsychological examination and quality of life measures
27 Unknown  Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients
Condition: Neurofibromatosis Type 1
Intervention:
28 Completed Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Condition: Neurofibromatosis 1
Intervention: Drug: Everolimus
29 Completed NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Condition: Neurofibromatosis Type 1
Intervention: Drug: methylphenidate
30 Completed Spinal Abnormalities in Neurofibromatosis Type 1 (NF1)
Condition: Neurofibromatosis Type 1
Intervention:
31 Unknown  A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Condition: Neurofibromatosis Type 1
Intervention: Drug: Sirolimus, Rapamycin
32 Enrolling by invitation Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
Condition: Neurofibromatosis 1
Intervention: Other: Blood sample
33 Completed Internet Support Group for Parents of a Child With Neurofibromatosis Type 1
Condition: Neurofibromatosis 1
Intervention:
34 Completed Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain
Condition: Neurofibromatosis
Intervention: Behavioral: ACT Workshop
35 Active, not recruiting Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
Conditions: Neurofibromatosis;   Neurofibromas
Intervention: Drug: Gleevec
36 Recruiting Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Condition: Neurofibromatosis Type 1
Interventions: Device: Magnetic resonance imaging;   Drug: Gadolinium contrast
37 Unknown  Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients
Condition: Neurofibromatosis Type 1
Intervention:
38 Recruiting Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1
Interventions: Other: CogmedRM;   Other: Mobymax
39 Completed
Has Results
Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
Condition: Neurofibromatosis
Intervention: Drug: Gleevec
40 Active, not recruiting Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF
Condition: Neurofibromatosis
Intervention: Other: Questionnaires

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.